CD70-Targeted [18F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study [0.03%]
针对鼻咽癌患者CD70的[18F]RCCB6免疫正电子发射断层扫描/X线计算机体层成像（PET/CT）概念验证性研究
Binyu Shi,You Zhang,Shuo Wu et al.
Binyu Shi et al.
CD70 has emerged as a promising biomarker for nasopharyngeal carcinoma (NPC). This study investigated CD70 expression patterns in NPC specimens and evaluated the diagnostic potential of CD70-targeted [18F]RCCB6 immuno-PET/CT in patients wit...
A Phase I/II Study of [177Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol [0.03%]
[177Lu]Lu-HTK03170精准化放量治疗转移性去势抵抗性前列腺癌的I/II期临床研究方案
Sara Harsini,Maryam Soleimani,Don Wilson et al.
Sara Harsini et al.
Prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals, such as the novel [177Lu]Lu-HTK03170, present a promising therapeutic option for metastatic castration-resistant prostate cancer (mCRPC). [177Lu]Lu-HTK03170, being us...
James T Thackeray
James T Thackeray
The Highlights Lecture, presented at the closing session of each SNMMI Annual Meeting, was originated and presented for more than 30 y by Henry N. Wagner, Jr., MD. Beginning in 2010, the duties of summarizing selected significant presentati...
Initial Experience with Dual-Time-Point [18F]Flurpiridaz PET/CT for Localization of Parathyroid Adenomas in Primary Hyperparathyroidism [0.03%]
18F]Flurpiridaz双时相PET/CT在原发性甲状旁腺功能亢进症定位甲状旁腺腺瘤中的初步应用体验
Thorsten Derlin,Dennis Kleine-Döpke,Lavinia Neubert et al.
Thorsten Derlin et al.
We aimed to evaluate the feasibility of [18F]flurpiridaz PET/CT for localization of parathyroid adenomas in patients with primary hyperparathyroidism (pHPT). Methods: Data for 11 patients with pHPT undergoing dual-time-point [18F]flurpirida...
Stakeholders of Theranostics: Thomas Beyer Talks with Richard Zimmermann About the Golden Age of Nuclear Medicine [0.03%]
分子影像与核医学的黄金时代：Thomas Beyer 访谈 Richard Zimmermann教授
Richard Zimmermann,Thomas Beyer
Richard Zimmermann
Swayamjeet Satapathy,Ashwani Sood
Swayamjeet Satapathy
Murat Tuncel,Gürsan Kaya,Oğuz Kodaz et al.
Murat Tuncel et al.
Multicycle Dosimetric Behavior and Dose-Effect Relationships in [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy [0.03%]
多周期剂量学行为及剂量效应关系在[177Lu]Lu-DOTATATE肽受体放射性核素治疗中的研究
Gunjan Kayal,Molly E Roseland,Chang Wang et al.
Gunjan Kayal et al.
We investigated pharmacokinetics, dosimetric patterns, and absorbed dose (AD)-effect correlations in [177Lu]Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) for metastatic neuroendocrine tumors (NETs) to develop strategies for futur...
Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data [0.03%]
基于真实世界数据的[177Lu]Lu-PSMA放射药剂治疗转移性去势抵抗性前列腺癌疗效监测的循证临床路径
Lena M Unterrainer,Nicolas De Leiris,Marcus Unterrainer et al.
Lena M Unterrainer et al.
Our objectives were to assess the prognostic value of posttherapy [177Lu]Lu-PSMA (LuPSMA) SPECT/CT by visual evaluation using RECIP 1.0 during LuPSMA therapy and develop an evidence-based clinical protocol to monitor the efficacy of LuPSMA....
Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long-Axial-Field-of-View PET/CT System [0.03%]
长轴视野PET/CT系统超低氟脱氧葡萄糖摄取正电子发射断层影像的可行性研究
Charlotte L C Smith,Gerben J C Zwezerijnen,Marijke E den Hollander et al.
Charlotte L C Smith et al.
18F-FDG PET/CT imaging is widely used in oncology. Long-axial-field-of-view (LAFOV) PET/CT systems exhibit ultrahigh sensitivity and signal-to-noise ratios, enabling significant reductions in tracer activity and shorter acquisition times. T...